Success Stories: EB-1A Approved for Project Scientist in California in the Field of Pharmacology
Client’s Testimonial:
Thank you for this good news. It was a pleasant experience to work with your team on my case. Without your tremendous input and timely reply, my case would not be approved so quickly. I will definitely introduce your service to people around me whenever there is a need.
On June 15, 2015, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Project Scientist in the Field of Pharmacology (Approval Notice)
Position at the Time of Case Filing: Project Scientist
Country of Origin: China
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: California
Approval Notice Date: June 15, 2015
Processing Time: 26 Days (13 days after Premium Processing was requested)
In this case, the client that we had the opportunity to work with was a project scientist from China in the field of pharmacology. Our client’s specialized research has focused on the development and enhancement of pharmacological treatments of psychiatric disorders and cancer. His work had resulted in 10 peer-reviewed scientific articles and 15 presentations at national and international conferences; at the time that his case was filed, his publications had been cited at least 160 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of his work. He had also reviewed 55 manuscripts for 86 times for distinctive, internationally-circulated journals. His superior level of expertise was confirmed in the following quote from an independent recommender, “[Client] is truly gifted, a claim that is supported by his extensive accomplishments in defining and advancing insight into the roles of monoamine oxidases (MAOs) in a host of neurological disorders.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of pharmacology, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in 26 days.